Affinity Investment Advisors, LLC United Therapeutics Corp Transaction History

Affinity Investment Advisors, LLC

  • $145 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022
SELL
$174.81 - $241.14 $288,436 - $397,881
-1,650 Closed
0 $0
Q1 2022

May 05, 2022
BUY
$166.16 - $213.96 $36,887 - $47,499
222 Added 15.55%
1,650 $296,000
Q4 2021

Feb 04, 2022
BUY
$184.32 - $216.08 $263,208 - $308,562
1,428 New
1,428 $309,000

Others Institutions Holding UTHR

# of Institutions
672
Shares Held
42.4M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Affinity Investment Advisors, LLC Portfolio

Follow Affinity Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email